| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other comprehensive income (loss) | 70 | - | ||
| Total comprehensive loss | -20,989 | -21,273 | ||
| Net loss per share - basic | -0.4 | -0.41 | ||
| Net loss per share - diluted | -0.4 | -0.41 | ||
| Weighted-average number of shares - basic | 52,993,238 | 52,010,827 | ||
| Weighted-average number of shares - diluted | 52,993,238 | 52,010,827 | ||
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP)